Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
Date:7/28/2009

t Loss Attributable to Lexicon Pharmaceuticals, Inc.: Net loss for the three months ended June 30, 2009 was $20.1 million, or $0.15 per share, compared to a net loss of $20.0 million, or $0.15 per share, in the corresponding period in 2008. Net loss for the six months ended June 30, 2009 was $41.6 million, or $0.30 per share, compared to a net loss of $38.0 million, or $0.28 per share, for the corresponding period in 2008. For the three and six months ended June 30, 2009, net loss included non-cash, stock-based compensation expense of $1.4 million and $2.8 million, respectively. For the three and six months ended June 30, 2008, net loss included non-cash, stock-based compensation expense of $1.6 million and $3.4 million, respectively.

Cash and Investments: As of June 30, 2009, Lexicon had $106.9 million in cash and investments net of its obligations under the credit line secured by its auction rate securities, as compared to $130.8 million as of March 31, 2009 and $158.8 million as of December 31, 2008.

Lexicon Conference Call:

Lexicon management will hold a conference call to discuss its clinical development progress and financial results for the second quarter of 2009 at 11:00 a.m. Eastern Time on July 28, 2009. The dial-in number for the conference call is 888-220-1244 (within the US/Canada) or 706-679-5615 (international). The conference ID for all callers is 17788499. Investors can access a live webcast of the call at www.lexpharma.com. An archived version of the webcast will be available on the website through August 4, 2009.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has five drug candidates in development for autoimmune disease, carcinoid syndrome, diabetes, glaucoma and irritable b
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
2. Millennium Pharmaceuticals Inc./Lymphoma Research Foundation funds lymphoma research
3. Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
4. Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
5. Sunesis Pharmaceuticals Appoints Helen S. Kim to Board of Directors
6. Hisamitsu Pharmaceutical Co., Inc. Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals, Inc.
7. Webcast Alert: Isis Pharmaceuticals Second Quarter 2009 Financial Results Conference Call
8. UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
9. Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference
10. Transcept Pharmaceuticals to Present at BMO Capital Markets Healthcare Conference on August 5, 2009
11. EPIX Pharmaceuticals, Inc. Assigns all Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... A 2014 study supported by the ... has found that rising temperatures and hotter ... children developing kidney stones. Researchers based their findings ... U.S. cities, including Dallas, Atlanta, Philadelphia, Chicago and Los ... for kidney stones within a relatively short span – ...
(Date:9/23/2014)... 23, 2014 ClickFunnels 2.0 ... application has created a buzz of excitement throughout the ... this new software has caught the attention of HonestyFirstReviews.com’s ... her readers. , “The technical aspects of ... and development can be quite daunting,” reports Hendricks. “In ...
(Date:9/23/2014)... from the University of Toronto, directed by Drs. ... in normal vestibular nerves and vestibular schwannomas (VSs). ... negligible difference between VSs that sporadically occur and ... a genetic disorder; and 2) the overexpressed PI3K/AKT/mTOR ... excellent therapeutic target. Detailed findings of this study ...
(Date:9/23/2014)... PA (PRWEB) September 23, 2014 Rinovum ... home-use conception assistance device on the market cleared by ... in stores and online at http://www.storkotc.com . , ... dream of having a baby is delayed by infertility1 ... first step to optimize their chances to conceive. ...
(Date:9/23/2014)... 2014 Ale Gicqueau, President and Chairman ... Data Visualization for Clinical Trials at the upcoming ... Francisco on Friday, September 26, 2014. , PhUSE ... its inception, PhUSE has expanded from its roots as ... platform for the discussion of topics encompassing the work ...
Breaking Medicine News(10 mins):Health News:New Study Finds Link Between Higher Temperatures and Kidney Stones in the United States 2Health News:New Study Finds Link Between Higher Temperatures and Kidney Stones in the United States 3Health News:ClickFunnels 2.0 – Review Of Russell Brunson’s Sales Funnel Building Software Released 2Health News:Aberrant PI3K/AKT/mTOR pathway found in vestibular schwanommas may be therapeutic target 2Health News:Aberrant PI3K/AKT/mTOR pathway found in vestibular schwanommas may be therapeutic target 3Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 2Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 3Health News:First-Ever Conception Assistance Device FDA-Cleared for Home Use Launches U.S. OTC Sales -- The Stork® OTC Delivers Hope to Millions Struggling to Conceive A Child 4Health News:Clinovo Sponsors and Presents at Pharmaceutical Users Software Exchange (PhUSE) SDE in San Francisco 2
... , ... Automates Consumer Tracking and Claims Workflow to Help Organizations Take Control of Medicaid Waivers ... Reston, ... in integrated health and human services management, announced today the immediate availability of ...
... ... also understands the value of providing excellent customer service to their customers. The customer ... A recent award from third party evaluators at STELLAService, ranks Anjolee high in three ... ...
... ... increase in business as the reward for providing personalized service and customized medications. The ... medicine. , ... Scottsdale, AZ (PRWEB) May 5, 2010 -- While important veterinary drugs remain in ...
... ... Yagodich – podiatrists at Your Next Step in Ardmore and Paoli, Pennsylvania – excitedly ... patients that suffer from toenail fungus. , ... Ardmore and Paoli, Pennsylvania (Vocus) May 4, 2010 -- ...
... ... and teff provide important nutrients for the gluten-free diet, but Carol Fenster bakes with sorghum ... To celebrate May as National Celiac Awareness month, she offers a free sorghum-based cookbook, Gluten-Free ... , ...
... helped some with respiratory disease, but more study ... Treatment with the antibiotic azithromycin doesn,t improve the ... fibrosis, U.S. researchers report. , "A vicious cycle ... and premature death in patients with cystic fibrosis ...
Cached Medicine News:Health News:Harmony Information Systems Announces Availability of Harmony for Aging Waivers Edition 2Health News:Harmony Information Systems Announces Availability of Harmony for Aging Waivers Edition 3Health News:Anjolee Receives Stellar Customer Service Award from STELLAService 2Health News:Scottsdale Veterinary Pharmacy Celebrates Success in Business By Dodging Veterinary Drug Shortages 2Health News:Scottsdale Veterinary Pharmacy Celebrates Success in Business By Dodging Veterinary Drug Shortages 3Health News:Over 450 Patients Now Toenail Fungus Free Thanks to Your Next Step's New Toenail Fungus Laser Treatment Technology 2Health News:Carol Fenster Offers Tips for Gluten-Free Cooking with Sorghum: May is National Celiac Awareness Month 2Health News:Azithromycin Doesn't Always Help Lungs in Cystic Fibrosis Patients 2
(Date:9/22/2014)... Sept. 22, 2014 Children,s National Health ... Sept. 29 at 5 p.m. EDT for its ... in response to continued strong interest from inventors.  ... will be awarded to the winning presentations at ... Symposium hosted by Children,s National in October. For ...
(Date:9/22/2014)... and SHANGHAI , Sept. ... (BHG), a global knowledge leader in healthcare technology, ... to support healthcare innovation in China ... connected health technologies. Continua and BHG announced this ... being held this week in Washington, ...
(Date:9/22/2014)... , Sept. 22, 2014 ... of the "Global Ablation Technologies (Radiofrequency, Ultrasound, ... 2019" report to their offering. ... the global ablation technologies market has been divided ... ultrasound, microwave, cryotherapy, hydrothermal, and hydromechanical ablation technologies. ...
Breaking Medicine Technology:Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3
The Select Series® Arterial Cannulae utilize a state-of-the-art dip-molding technology. This process allows molding of a one-piece, wire-wound cannula that is flexible and kink-resistant....
Intermittent catheter...
... assay is a rapid and accurate bedside test ... assisting the diagnosis and assessment of patients with ... speed and accuracy profit from a ... assay = 12 minutes. In emergency departments Point ...
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
Medicine Products: